Blume-Jensen Peter sold ACRV
November 14, 2025 · Form 4 insider transaction
Blume-Jensen Peter sold 59,765 shares of Acrivon Therapeutics, Inc. at $2.24 per share, a transaction worth $133.9K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
59,765
Price
$2.24
Total value
$133.9K
InsiderBlume-Jensen Peter
RoleOfficer, Director
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateNovember 14, 2025
Filing dateNovember 18, 2025
Shares owned after2,066,675
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.; These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.